Nabriva Therapeutics AG ADR buy klostergang
Start price
25.08.17
/
50%
?7.59
Target price
27.08.18
€15.64
Performance (%)
-67.54%
End price
27.08.18
€2.46
Summary
This prediction ended on 27.08.18 with a price of €2.46. Massive losses of -67.54% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nabriva Therapeutics AG ADR | - | - | - | - |
iShares Core DAX® | -1.226% | 2.804% | 14.933% | 16.561% |
iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% | 54.743% |
iShares Nikkei 225® | -1.132% | -2.218% | 5.361% | 4.560% |
iShares S&P 500 | -0.980% | 1.883% | 22.727% | 45.760% |
Comments by klostergang for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
klostergang stimmt der Outperform-Einschätzung der institutionellen Analysten zu
klostergang stimmt am 25.08.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 17.34$ zu.
(Laufzeit überschritten)